Fresita Proteins Limited files Letter of Offer for Rights Issue opening Nov 12, 2026
Sarda Proteins · Agricultural Food & other Products
Key highlights
- Rights Issue of up to 74,79,917 Equity Shares of face value ₹10 at ₹120 per share, aggregating up to ₹8975.90 Lakhs
- Issue opens November 12, 2026 and closes November 26, 2026, in the ratio of 5 Rights Equity Shares for every 6 held on record date October 30, 2026
- BSE has given in-principle approval for listing the Rights Equity Shares by letter dated October 08, 2026; Letter of Offer dated October 29, 2026
Why it's rated notable: the amount is 45% of market value (20% to 50%)
Figures checked against the filing by a second AI read, which corrected the first summary. About the business, not the share price.
Original filing
Letter Of Offer For The Rights Issue Of Equity Shares Of The Company
Read the filing on BSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Electrical Equipment
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Other fundraise / allotment filings this fortnight
- Clean Max Enviro: Q2 results, NCDs up to Rs 3,000 crore approved, IFSC subsidiary planned
- Lloyds Metals and Energy Limited approves Q2 results, investment, and fundraising plans
- Lloyds Metals approves Q2 results, ₹625 crore TEIL investment and USD 300 million debt
- Mena Mani Industries approves Sept 2026 results, hotel venture and software expansion
- Sat Kartar Life Limited receives NSE approval for 5,50,000 convertible warrants issue
- CL Educate Limited approves ₹140 Cr fund raise and reports Q2 FY27 financials
Potential multibaggers · Q2 FY27
Potential multibaggers in Agricultural Food & other Products
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.